PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,058,408 | -42.0% | 7,945,489 | +5.2% | 0.00% | -42.9% |
| Q2 2023 | $307,159,240 | -16.4% | 7,552,477 | -0.5% | 0.01% | -22.2% |
| Q1 2023 | $367,552,160 | +31.2% | 7,587,782 | +3.4% | 0.01% | +12.5% |
| Q4 2022 | $280,149,478 | -22.6% | 7,339,520 | +1.8% | 0.01% | -27.3% |
| Q3 2022 | $362,027,000 | +25.8% | 7,211,720 | +0.4% | 0.01% | +37.5% |
| Q2 2022 | $287,780,000 | +11.3% | 7,183,692 | +3.6% | 0.01% | +33.3% |
| Q1 2022 | $258,673,000 | -5.7% | 6,933,076 | +0.6% | 0.01% | 0.0% |
| Q4 2021 | $274,386,000 | +9.1% | 6,888,909 | +1.9% | 0.01% | 0.0% |
| Q3 2021 | $251,465,000 | -11.7% | 6,757,974 | +0.3% | 0.01% | -14.3% |
| Q2 2021 | $284,672,000 | -5.9% | 6,734,630 | +5.4% | 0.01% | -12.5% |
| Q1 2021 | $302,512,000 | -20.1% | 6,388,856 | +3.0% | 0.01% | -27.3% |
| Q4 2020 | $378,445,000 | +38.9% | 6,200,967 | +6.4% | 0.01% | +22.2% |
| Q3 2020 | $272,450,000 | -5.3% | 5,827,812 | +2.7% | 0.01% | -10.0% |
| Q2 2020 | $287,815,000 | +15.6% | 5,672,336 | +1.7% | 0.01% | -9.1% |
| Q1 2020 | $248,886,000 | -4.8% | 5,579,171 | +2.5% | 0.01% | +22.2% |
| Q4 2019 | $261,362,000 | +49.5% | 5,441,640 | +5.3% | 0.01% | +50.0% |
| Q3 2019 | $174,849,000 | -23.4% | 5,169,992 | +2.0% | 0.01% | -33.3% |
| Q2 2019 | $228,180,000 | +22.0% | 5,070,674 | +2.1% | 0.01% | +28.6% |
| Q1 2019 | $187,002,000 | +18.6% | 4,968,189 | +8.1% | 0.01% | 0.0% |
| Q4 2018 | $157,739,000 | -24.7% | 4,596,105 | +3.1% | 0.01% | -12.5% |
| Q3 2018 | $209,539,000 | +94.3% | 4,458,295 | +39.4% | 0.01% | +60.0% |
| Q2 2018 | $107,839,000 | +34.6% | 3,197,129 | +8.0% | 0.01% | +25.0% |
| Q1 2018 | $80,116,000 | +73.0% | 2,960,664 | +6.7% | 0.00% | +100.0% |
| Q4 2017 | $46,297,000 | -21.2% | 2,775,655 | -5.4% | 0.00% | -33.3% |
| Q3 2017 | $58,735,000 | +35.4% | 2,935,293 | +24.0% | 0.00% | +50.0% |
| Q2 2017 | $43,379,000 | +118.2% | 2,366,564 | +17.2% | 0.00% | +100.0% |
| Q1 2017 | $19,877,000 | -5.0% | 2,020,039 | +5.3% | 0.00% | 0.0% |
| Q4 2016 | $20,934,000 | -19.2% | 1,918,708 | +3.7% | 0.00% | -50.0% |
| Q3 2016 | $25,911,000 | +58.4% | 1,849,447 | -20.6% | 0.00% | +100.0% |
| Q2 2016 | $16,355,000 | +23.3% | 2,329,802 | +13.1% | 0.00% | 0.0% |
| Q1 2016 | $13,268,000 | -80.0% | 2,060,160 | +0.7% | 0.00% | -75.0% |
| Q4 2015 | $66,303,000 | +24.7% | 2,046,376 | +2.7% | 0.00% | +100.0% |
| Q3 2015 | $53,186,000 | -35.8% | 1,991,960 | +15.8% | 0.00% | -66.7% |
| Q2 2015 | $82,803,000 | -16.6% | 1,720,391 | +5.5% | 0.01% | -14.3% |
| Q1 2015 | $99,225,000 | +63.1% | 1,630,637 | +38.8% | 0.01% | +75.0% |
| Q4 2014 | $60,839,000 | +144.2% | 1,175,176 | +107.6% | 0.00% | +100.0% |
| Q3 2014 | $24,909,000 | +73.6% | 565,998 | +3.1% | 0.00% | +100.0% |
| Q2 2014 | $14,345,000 | +17.8% | 548,804 | +17.8% | 0.00% | 0.0% |
| Q1 2014 | $12,180,000 | +386.8% | 465,955 | +216.0% | 0.00% | – |
| Q4 2013 | $2,502,000 | +111.3% | 147,449 | +167.2% | 0.00% | – |
| Q3 2013 | $1,184,000 | – | 55,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |